Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready
Neuron23 Inc. has 3 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are assigned to 3 distinct examiners and 3 distinct art units. CHAO, ALLEN is the busiest examiner, overseeing 1 pending office action. The presence of 3 distinct art units for 3 pending actions indicates that each matter is being reviewed in a different technical section.
This distribution requires the company to manage 3 distinct examiner relationships simultaneously. The fact that each of the 3 distinct examiners handles 1 pending office action suggests that no single individual dominates the current workload. Practitioners must adapt their strategies to the specific requirements of 3 different art units within the biotechnology sector.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §102 only | 2 (67%) |
| §112 only | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CHAO, ALLEN | 1 | 55.6% | +0.0% |
| FERGUSON, JALISA HOLMES | 1 | 61.1% | +43.8% |
| MCDOWELL, BRIAN E | 1 | 74.1% | +30.8% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18375063 | KINASE MODULATORS AND METHODS OF USE THEREOF | FERGUSON, JALISA HOLMES | 92d overdue |
| 18036549 | KINASE MODULATORS AND METHODS OF USE THEREOF | MCDOWELL, BRIAN E | 29d |
| Art Unit | Apps |
|---|---|
| 1622 | 1 |
| 1626 | 1 |
| 1624 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18512306 | LRRK2 INHIBITORS AND USES THEREOF | CHAO, ALLEN | 1622 | §102 | Non-Final OA | — | Pending | Nov 17, 2023 |
| 18375063 | KINASE MODULATORS AND METHODS OF USE THEREOF | FERGUSON, JALISA HOLMES | 1626 | §102 | Final Rejection | 92d overdue | Pending | Sep 29, 2023 |
| 18036549 | KINASE MODULATORS AND METHODS OF USE THEREOF | MCDOWELL, BRIAN E | 1624 | §112 | Non-Final OA | 29d | Pending | May 11, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial